38 research outputs found
Assessment of the phytochemical constituents and antioxidant activity of a bloom forming microalgae Euglena tuba
BACKGROUND: Unstable generation of free radicals in the body are responsible for many degenerative diseases. A bloom forming algae Euglena tuba growing abundantly in the aquatic habitats of Cachar district in the state of Assam in North-East India was analysed for its phytochemical contents, antioxidant activity as well as free radical scavenging potentials. RESULTS: Based on the ability of the extract in ABTS•+ radical cation inhibition and Fe3+ reducing power, the obtained results revealed the prominent antioxidant activity of the algae, with high correlation coefficient of its TEAC values to the respective phenolic and flavonoid contents. The extract had shown its scavenging activity for different free radicals and 41.89 ± 0.41 µg/ml, 5.83 ± 0.07 µg/ml, 278.46 ± 15.02 µg/ml and 223.25 ± 4.19 µg/ml were determined as the IC50 values for hydroxyl, superoxide, nitric oxide and hypochlorous acid respectively, which are lower than that of the corresponding reference standards. The phytochemical analysis also revealed that the phenolics, flavonoids, alkaloids, tannins and carbohydrates are present in adequate amount in the extract which was confirmed by HPLC analysis. CONCLUSIONS: The results showed that 70% methanol extract of the algae possesses excellent antioxidant and free radical scavenging properties
An antioxidant extract of tropical lichen, Parmotrema reticulatum, induces cell cycle arrest and apoptosis in breast carcinoma cell line MCF-7.
This report highlights the phytochemical analysis, antioxidant potential and anticancer activity against breast carcinoma of 70% methanolic extract of lichen, Parmotrema reticulatum (PRME). Phytochemical analysis of PRME confirms the presence of various phytoconstituents like alkaloids, carbohydrates, flavonoids, glycosides, phenols, saponins, tannins, anthraquinones, and ascorbic acid; among which alkaloids, phenols and flavonoids are found in abundant amount. High performance liquid chromatography (HPLC) analysis of PRME revealed the presence of catechin, purpurin, tannic acid and reserpine. Antioxidant activity was evaluated by nine separate methods. PRME showed excellent hydroxyl and hypochlorous radical scavenging as well as moderate DPPH, superoxide, singlet oxygen, nitric oxide and peroxynitrite scavenging activity. Cytotoxicity of PRME was tested against breast carcinoma (MCF-7), lung carcinoma (A549) and normal lung fibroblast (WI-38) using WST-1 method. PRME was found cytotoxic against MCF-7 cells with an IC50 value 130.03 ± 3.11 µg/ml while negligible cytotoxicity was observed on A549 and WI-38 cells. Further flow cytometric study showed that PRME halted the MCF-7 cells in S and G2/M phases and induces apoptosis in dose as well as time dependent manner. Cell cycle arrest was associated with downregulation of cyclin B1, Cdk-2 and Cdc25C as well as slight decrease in the expression of Cdk-1 and cyclin A1 with subsequent upregulation of p53 and p21. Moreover PRME induced Bax and inhibited Bcl-2 expression, which results in increasing Bax/Bcl-2 ratio and activation of caspase cascade. This ultimately leads to PARP degradation and induces apoptosis in MCF-7 cells. It can be hypothesised from the current study that the antioxidant and anticancer potential of the PRME may reside in the phytoconstitutents present in it and therefore, PRME may be used as a possible source of natural antioxidant that may be developed to an anticancer agent
Leishmania donovani Infection of Human Myeloid Dendritic Cells Leads to a Th1 Response in CD4+ T Cells from Healthy Donors and Patients with Kala-Azar.
The role played by dendritic cells (DCs) in Leishmania donovani infection is poorly understood. Here, we
report that L. donovani amastigotes efficiently infect human peripheral-blood monocyte–derived DCs. Opsonization
with normal human serum enhanced the infectivity of amastigotes and promastigotes only marginally.
Surface attachment versus internalization was distinguished by incubation of DCs with live, fluorescein isothiocyanate–labeled parasites, followed by quenching with crystal violet. Infection with amastigotes was accompanied by DC maturation, as was evident from the up-regulation of maturation-associated cell-surface markers, the nuclear translocation of RelB, and the release of cytokines. Amastigote-primed DCs produced inflammatory cytokines in response to subsequent treatment with interferon-g or anti-CD40 monoclonal antibody. When cocultured, amastigote-infected DCs induced T helper cell type 1 (Th1) responses both in naive allogeneic CD4+ T cells and in autologous CD4+ T cells from patients with kala-azar and up-regulated the expression of T-bet. Our data reveal that infection with L. donovani amastigotes induces a Th1 cytokine milieu in both DCs and T cells
N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl+ cells by endothelial nitric oxide synthase-mediated production of nitric oxide
Introduction Imatinib, a small-molecule inhibitor of the
Bcr-Abl kinase, is a successful drug for treating chronic
myeloid leukemia (CML). Bcr-Abl kinase stimulates the
production of H2O2, which in turn activates Abl kinase. We
therefore evaluated whether N-acetyl cysteine (NAC), a
ROS scavenger improves imatinib efficacy.
Materials and methods Effects of imatinib and NAC
either alone or in combination were assessed on Bcr-Abl?
cells to measure apoptosis. Role of nitric oxide (NO) in
NAC-induced enhanced cytotoxicity was assessed using
pharmacological inhibitors and siRNAs of nitric oxide
synthase isoforms. We report that imatinib-induced apoptosis
of imatinib-resistant and imatinib-sensitive Bcr-Abl?
CML cell lines and primary cells from CML patients significantly enhanced by co-treatment with NAC compared
to imatinib treatment alone. In contrast, another ROS
scavenger glutathione reversed imatinib-mediated killing.
NAC-mediated enhanced killing correlated with cleavage
of caspases, PARP and up-regulation and down regulation
of pro- and anti-apoptotic family of proteins, respectively.
Co-treatment with NAC leads to enhanced production
of nitric oxide (NO) by endothelial nitric oxide synthase
(eNOS). Involvement of eNOS dependent NO in NACmediated
enhancement of imatinib-induced cell death was
confirmed by nitric oxide synthase (NOS) specific pharmacological
inhibitors and siRNAs. Indeed, NO donor
sodium nitroprusside (SNP) also enhanced imatinib-mediated
apoptosis of Bcr-Abl? cells.
Conclusion NAC enhances imatinib-induced apoptosis
of Bcr-Abl? cells by endothelial nitric oxide synthasemediated
production of nitric oxide
Micellar catalysis of chromium(VI) oxidation of ethane-1,2-diol in the presence and absence of 2,2′-bipyridine in aqueous acid media
Qualitative and quantitative phytochemical analysis of PRME.
<p>“+” represents presence of the phytoconstituent; “−” represents absence of the phytoconstituent; “ND” represents “Not determined”.<sup></sup> Phen- Phenol, Flav- Flavonoid, Carbo- Carbohydrate, Tan.- Tannin, Alka- Alkaloid, Asc- Ascorbic acid, Ter- Terpenoids, Triter- Triterpenoids, Anth-Anthraquinones, Sap- Saponin, Gly- Glycoside; Total phenolics (mg/100 mg extract gallic acid equivalent), Total flavonoids (mg/100 mg extract quercetin equivalent), Carbohydtrate (mg/100 mg extract glucose equivalent), Tannin (mg/100 mg extract catechin equivalent). Alkaloid (mg/100 mg extract reserpine equivalent), Ascorbic acid (mg/100 mg extract L-ascorbic acid equivalent) </p
Reactive Oxygen species scavenging activity of PRME and the reference compounds.
<p>(A) Hydroxyl radical inhibition, (B) hypochlorous radical scavenging, (C) superoxide radical inhibition, (D) singlet oxygen radical scavenging. The results are mean ± S.D. of six parallel measurements. **p<0.01 and ***p<0.001 vs. 0 µg/ml.</p
HPLC chromatogram of PRME.
<p>Inset shows expanded region of the chromatogram with retention time of 4.5–10 minutes. Peaks marked signify the retention peak of purpurin (2.4 min), catechin (3.13 min), tannic acid (3.64 min) and reserpine (4.68 min).</p